SA organisations chosen to address HIV/AIDS globally
USAID has recognised the expertise of two South African-led consortia to address the global challenge of treating those infected by HIV/AIDS. These consortia are led by Right to Care and the Wits Reproductive Health and HIV Institute (Wits RHI). They will apply the innovations and lessons learned in South Africa to strengthen programmes in countries across Africa.Right to Care‚ a non-profit organisation that offers prevention‚ care‚ and treatment for HIV‚ TB‚ cervical cancer‚ medical male circumcision and sexually transmitted infections is leading the Equip consortium of five organisations that have developed a variety of innovative approaches to HIV care and treatment. These include Anova Health Institute‚ Khethimpilo‚ Maternal Adolescent and Child Health Systems (MatCH) and Partners in Hope. They have strong relationships with USAID missions and departments of health as well as more than fifty years of collective experience working in HIV/AIDS in Africa.Wits RHI‚ a leading academic research institution working in the fields of sexual reproductive health‚ HIV and vaccinology‚ will lead efforts to simplify treatment by investigating how medicine for HIV can become more effective and affordable. The consortium includes ICAP at Columbia University‚ Mylan Laboratories‚ the University of Liverpool and the Medicines Patent Pool. The consortium will be supported by key partners including UNITAID and the South African Medical Research Council (SAMRC).The consortia will work to simplify treatment; increase HIV testing and access to treatment; link people living with HIV to care; develop laboratory capacity; target most at-risk populations to ensure they continue to follow prescribed treatment and receive the proper care‚ and reduce the cost and increase the effectiveness of ART through research and innovation.The US Government and multinational agencies such as UNAIDS have set three key targets for the global campaign in fighting HIV/AIDS: - 90% of HIV positive people should be identified - 90% should be in care and on treatment - 90% should have an undetectable viral load.